Pharmacy leaders from Cone Health discuss how robotic compounding technologies have improved safety, accuracy, and reliability in hazardous and sterile medication preparation across oncology and acute care settings.
Melody Smith, MD, MS, discusses how microbiome modulation may influence CAR T-cell therapy toxicity and outcomes, highlighting potential future interventions and clinical integration challenges.
The treatment could hold significant potential for major depressive disorder
Donna Ryan explains why long-term treatment with GLP-1 medication is typically necessary to maintain weight loss benefits.
Pharmacists improve outcomes by clarifying and delabeling inaccurate antibiotic allergies.
Complete due diligence before selecting a compounding pharmacy and establishing an outsourcing relationship.
Cyclin-dependent kinase 4/6 (CDK 4/6) inhibitors have transformed the treatment of hormone receptor-positive/HER2-negative breast cancer across metastatic and early-stage settings, with ongoing research exploring their potential in additional breast cancer subtypes, combination therapies, and aggressive disease scenarios.
It’s imperative to redefine the future of pharmacy to help ensure a robust pipeline of future pharmacists and create a culture that helps ensure pharmacists live their purpose and passion.
Implementation of yearly mock code training can reinforce essential knowledge and increase pharmacists’ clinical competence and confidence when faced with actual neonatal and pediatric emergencies.
It's key for clinicians to optimize therapy prior to systemic agents.
Pharmacist interactions provide significant benefits for patients with non-small cell lung cancer treated with oral oncolytics.
Innovative experiential learning can provide students with skills necessary to launch successful careers, keeping the pharmacy profession trusted by patients.
With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
Currently, no national pharmacy organization has defined wellness in the pharmacy profession, which is needed so that others have a sense of guidance around wellness within the profession.
Rebyota is a live biotherapeutic product that is unfamiliar to many pharmacists and other health care providers with different steps in the eventual administration process.
Evidence suggests that there are many barriers to the proper implementation of MTM services, including time constraints and lack of staff support.
Pharmacists play a key role in educating patients and prescribers on the selection, use, and management of GLP-1 receptor agonists in diabetes care.
Current treatment strategies are aimed at reducing hematocrit and symptom burden through phlebotomy, aspirin, and cytoreductive agents, while emerging therapies offer promise for better disease control and quality of life.
Idaho State University partners with the Idaho Immunization Coalition to effectively and safely vaccinate patients against influenza.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Initiating and optimizing heart failure guideline-directed medical therapy is critical to the comprehensive management of heart failure.
Although pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.
Building a network, finding your passion, and taking steps to transition into an industry professional can help lead PharmD graduates to success.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.
This CAR T-cell therapy has revolutionized the management of high-risk and relapsed or refractory disease.
The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.
With shifts in health care moving toward AI and automation, issues relating to how these innovations may impact patient safety continue to emerge.